Basit öğe kaydını göster

dc.contributor.authorBozkurt, Turgut Emrah
dc.date.accessioned2021-06-03T08:50:27Z
dc.date.available2021-06-03T08:50:27Z
dc.date.issued2019
dc.identifier.issn1420-3049
dc.identifier.urihttp://dx.doi.org/10.3390/molecules24244626
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943521/
dc.identifier.urihttp://hdl.handle.net/11655/24340
dc.description.abstractCannabinoids and the mammalian endocannabinoid system is an important research area of interest and attracted many researchers because of their widespread biological effects. The significant immune-modulatory role of cannabinoids has suggested their therapeutic use in several inflammatory conditions. Airways are prone to environmental irritants and stimulants, and increased inflammation is an important process in most of the respiratory diseases. Therefore, the main strategies for treating airway diseases are suppression of inflammation and producing bronchodilation. The ability of cannabinoids to induce bronchodilation and modify inflammation indicates their importance for airway physiology and pathologies. In this review, the contribution of cannabinoids and the endocannabinoid system in the airways are discussed, and the existing data for their therapeutic use in airway diseases are presented.
dc.language.isoen
dc.relation.isversionof10.3390/molecules24244626
dc.rightsAttribution 4.0 United States
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleEndocannabinoid System In The Airways
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalMolecules
dc.contributor.departmentFarmakoloji
dc.identifier.volume24
dc.identifier.issue24
dc.description.indexPubMed
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

Attribution 4.0 United States
Aksi belirtilmediği sürece bu öğenin lisansı: Attribution 4.0 United States